GJIA
TECH icon

Glass Jacobson Investment Advisors’s Bio-Techne TECH Stock Holding History

Glass Jacobson Investment Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10
Closed -$681 – 820
2023
Q3 		$681 Hold
10
– – ﹤0.01% 724
2023
Q2 		$817 Buy
+10
New +$804 ﹤0.01% 718
2022
Q4 		$829 Buy
+10
New +$794 ﹤0.01% 750

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Glass Jacobson Investment Advisors's TECH Position: Q4 2023 in Review

Glass Jacobson Investment Advisors sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 10 shares — an estimated $681 sold.

Glass Jacobson Investment Advisors first reported a position in TECH in Q4 2022 and held it in 3 quarters. The position peaked at $829 in Q4 2022. 530 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

  • Glass Jacobson Investment Advisors reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
  • Glass Jacobson Investment Advisors sold 10 Bio-Techne shares in Q4 2023, an estimated $681.
  • Glass Jacobson Investment Advisors first reported a position in Bio-Techne in Q4 2022 and held it in 3 quarters.
  • Glass Jacobson Investment Advisors's Bio-Techne position peaked at $829 in Q4 2022.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Glass Jacobson Investment Advisors's 13F filing for Q4 2023, filed 22 Jan 2024.